FDANonrulemakingFDA-2024-D-1334

Who commented on this docket

Notifying FDA of a Permanent Discontinuance in the Manufacture or an Interruption of the Manufacture of an Infant Formula; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request

2 organizations filed 2 public comments on Notifying FDA of a Permanent Discontinuance in the Manufacture or an Interruption of the Manufacture of an Infant Formula; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request, at the Food and Drug Administration. The comment window closed 540d ago.

Organizations
2
Comments
2
RIN
Comment window
closed 540d ago

Abstract

OPEN

Commenters (2)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.